We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis Recalls Products After FDA Inspection
Actavis Recalls Products After FDA Inspection
August 5, 2008
Actavis Totowa, a U.S. subsidiary of Icelandic generic drug firm Actavis, is recalling all drug products manufactured at its plant in Little Falls, N.J., after an FDA inspection revealed the products were not made according to GMP standards.